Matches in Nanopublications for { ?s ?p ""Y Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated cardiac failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product. Known hypersensitivity to product components. ( 4 Severe bradycardia. ( 4 Heart block greater than first degree. ( 4 Cardiogenic shock. ( 4 Decompensated cadiac failure. ( 4 Sick sinus syndrome without a pacemaker. ( 4"" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label ""Y Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated cardiac failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product. Known hypersensitivity to product components. ( 4 Severe bradycardia. ( 4 Heart block greater than first degree. ( 4 Cardiogenic shock. ( 4 Decompensated cadiac failure. ( 4 Sick sinus syndrome without a pacemaker. ( 4"" assertion.